Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
Identification of COL6A1 as the Key Gene Associated with Antivascular Endothelial Growth Factor Therapy in Glioblastoma Multiforme
Genetic Testing and Molecular Biomarkers  (IF1.795),  Pub Date : 2021-05-17, DOI: 10.1089/gtmb.2020.0279
Han Lin, Yong Yang, Chongxian Hou, Jiantao Zheng, Guangzhao Lv, Rui Mao, Peihong Xu, Shanwei Chen, Yujun Zhou, Peng Wang, Dong Zhou

Background: Vascular endothelial growth factors (VEGFs) are important for glioblastoma multiforme (GBM) growth and development. However, the effects of VEGF-targeting drugs in primary GBM remain poorly understood.